Immunonutrition in head and neck cancer patients undergoing chemoradiotherapy: an alternative approach for overcoming potential bias
- PMID: 33822867
- DOI: 10.1093/ajcn/nqaa421
Immunonutrition in head and neck cancer patients undergoing chemoradiotherapy: an alternative approach for overcoming potential bias
Comment in
-
Reply to Caccialanza et al.Am J Clin Nutr. 2021 Apr 6;113(4):1054-1055. doi: 10.1093/ajcn/nqaa425. Am J Clin Nutr. 2021. PMID: 33822866 No abstract available.
Comment on
-
A double-blind phase III trial of immunomodulating nutritional formula during adjuvant chemoradiotherapy in head and neck cancer patients: IMPATOX.Am J Clin Nutr. 2020 Dec 10;112(6):1523-1531. doi: 10.1093/ajcn/nqaa227. Am J Clin Nutr. 2020. PMID: 32936874 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical